MS Methylprednisolone treatment can be a double-edged sword.  As bad as people suffer with Multiple Sclerosis, Methylprednisolone treatment often ends up making them suffer more.  It is often used alone, or in combination with interferon beta – 1a in an attempt to improve the outcome for RRMS or relapsing-remitting MS.  Like most treatment regimens for Multiple Sclerosis, methylprednisolone needs to be evaluated on an individual basis to see if the side effects outweigh the benefits.  In a Denmark study recently, that was published in “The Lancet Neurology” 130 patients were studied that were being treated for relapsing-remitting Multiple Sclerosis.  Methylprednisolone was added both orally and intravenously to half of the group along with their interferon beta – 1a.  Of the patients taking interferon for the MS, methylprednisolone added either orally or intravenously cut the relapse rate roughly in half.  But the effect was short lasting and worst of all, one …